Mutations in the deubiquitinase gene USP8 cause Cushing's disease

Martin Reincke, Martin Fassnacht and colleagues identify somatic mutations in the USP8 deubiquitinase gene in corticotroph adenomas in Cushing's disease. The mutations enhanced proteolytic cleavage and catalytic activity of USP8, which led to activation of EGF receptor signaling. Cushing's...

Full description

Saved in:
Bibliographic Details
Published inNature genetics Vol. 47; no. 1; pp. 31 - 38
Main Authors Reincke, Martin, Sbiera, Silviu, Hayakawa, Akira, Theodoropoulou, Marily, Osswald, Andrea, Beuschlein, Felix, Meitinger, Thomas, Mizuno-Yamasaki, Emi, Kawaguchi, Kohei, Saeki, Yasushi, Tanaka, Keiji, Wieland, Thomas, Graf, Elisabeth, Saeger, Wolfgang, Ronchi, Cristina L, Allolio, Bruno, Buchfelder, Michael, Strom, Tim M, Fassnacht, Martin, Komada, Masayuki
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.01.2015
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN1061-4036
1546-1718
1546-1718
DOI10.1038/ng.3166

Cover

More Information
Summary:Martin Reincke, Martin Fassnacht and colleagues identify somatic mutations in the USP8 deubiquitinase gene in corticotroph adenomas in Cushing's disease. The mutations enhanced proteolytic cleavage and catalytic activity of USP8, which led to activation of EGF receptor signaling. Cushing's disease is caused by corticotroph adenomas of the pituitary. To explore the molecular mechanisms of endocrine autonomy in these tumors, we performed exome sequencing of 10 corticotroph adenomas. We found somatic mutations in the USP8 deubiquitinase gene in 4 of 10 adenomas. The mutations clustered in the 14-3-3 protein binding motif and enhanced the proteolytic cleavage and catalytic activity of USP8. Cleavage of USP8 led to increased deubiqutination of the EGF receptor, impairing its downregulation and sustaining EGF signaling. USP8 mutants enhanced promoter activity of the gene encoding proopiomelanocortin. In summary, our data show that dominant mutations in USP8 cause Cushing's disease via activation of EGF receptor signaling.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-2
content type line 23
ISSN:1061-4036
1546-1718
1546-1718
DOI:10.1038/ng.3166